Teleflex Current Ratio 2010-2025 | TFX
Current and historical current ratio for Teleflex (TFX) from 2010 to 2025. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Teleflex current ratio for the three months ending June 30, 2025 was 2.41.
| Teleflex Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2025-06-30 | $1.72B | $0.72B | 2.41 |
| 2025-03-31 | $1.54B | $0.68B | 2.28 |
| 2024-12-31 | $1.47B | $0.65B | 2.27 |
| 2024-09-30 | $1.50B | $0.62B | 2.42 |
| 2024-06-30 | $1.44B | $0.56B | 2.58 |
| 2024-03-31 | $1.43B | $0.57B | 2.51 |
| 2023-12-31 | $1.41B | $0.61B | 2.32 |
| 2023-09-30 | $2.10B | $0.59B | 3.58 |
| 2023-06-30 | $1.45B | $0.56B | 2.60 |
| 2023-03-31 | $1.43B | $0.58B | 2.48 |
| 2022-12-31 | $1.41B | $0.58B | 2.43 |
| 2022-09-30 | $1.46B | $0.61B | 2.39 |
| 2022-06-30 | $1.39B | $0.61B | 2.27 |
| 2022-03-31 | $1.49B | $0.66B | 2.28 |
| 2021-12-31 | $1.43B | $0.68B | 2.10 |
| 2021-09-30 | $1.54B | $0.56B | 2.74 |
| 2021-06-30 | $1.44B | $0.53B | 2.73 |
| 2021-03-31 | $1.38B | $0.51B | 2.71 |
| 2020-12-31 | $1.42B | $0.54B | 2.63 |
| 2020-09-30 | $1.42B | $0.48B | 2.99 |
| 2020-06-30 | $1.55B | $0.46B | 3.38 |
| 2020-03-31 | $1.45B | $0.40B | 3.60 |
| 2019-12-31 | $1.31B | $0.56B | 2.32 |
| 2019-09-30 | $1.24B | $0.53B | 2.33 |
| 2019-06-30 | $1.25B | $0.49B | 2.52 |
| 2019-03-31 | $1.18B | $0.52B | 2.27 |
| 2018-12-31 | $1.24B | $0.58B | 2.12 |
| 2018-09-30 | $1.24B | $0.55B | 2.26 |
| 2018-06-30 | $1.19B | $0.54B | 2.21 |
| 2018-03-31 | $1.21B | $0.55B | 2.18 |
| 2017-12-31 | $1.13B | $0.48B | 2.33 |
| 2017-09-30 | $1.77B | $0.38B | 4.72 |
| 2017-06-30 | $1.41B | $0.38B | 3.74 |
| 2017-03-31 | $1.40B | $0.39B | 3.56 |
| 2016-12-31 | $1.18B | $0.43B | 2.77 |
| 2016-09-30 | $1.16B | $0.45B | 2.57 |
| 2016-06-30 | $1.16B | $0.42B | 2.74 |
| 2016-03-31 | $1.09B | $0.68B | 1.61 |
| 2015-12-31 | $1.00B | $0.66B | 1.51 |
| 2015-09-30 | $1.04B | $0.66B | 1.58 |
| 2015-06-30 | $1.10B | $0.66B | 1.67 |
| 2015-03-31 | $1.07B | $0.66B | 1.61 |
| 2014-12-31 | $1.00B | $0.63B | 1.57 |
| 2014-09-30 | $1.08B | $0.68B | 1.59 |
| 2014-06-30 | $1.04B | $0.65B | 1.60 |
| 2014-03-31 | $1.22B | $0.63B | 1.93 |
| 2013-12-31 | $1.20B | $0.64B | 1.89 |
| 2013-09-30 | $1.11B | $0.27B | 4.15 |
| 2013-06-30 | $1.06B | $0.26B | 4.01 |
| 2013-03-31 | $1.06B | $0.26B | 4.04 |
| 2012-12-31 | $1.07B | $0.28B | 3.90 |
| 2012-09-30 | $1.29B | $0.25B | 5.20 |
| 2012-06-30 | $1.25B | $0.24B | 5.15 |
| 2012-03-31 | $1.32B | $0.28B | 4.80 |
| 2011-12-31 | $1.28B | $0.27B | 4.72 |
| 2011-09-30 | $1.19B | $0.38B | 3.09 |
| 2011-06-30 | $1.15B | $0.36B | 3.15 |
| 2011-03-31 | $0.93B | $0.34B | 2.71 |
| 2010-12-31 | $0.92B | $0.42B | 2.19 |
| 2010-09-30 | $1.04B | $0.47B | 2.24 |
| 2010-06-30 | $1.04B | $0.32B | 3.22 |
| 2010-03-31 | $0.99B | $0.32B | 3.06 |
| 2009-12-31 | $1.00B | $0.34B | 2.98 |
| 2009-09-30 | $0.95B | $0.33B | 2.90 |
| 2009-06-30 | $0.93B | $0.34B | 2.72 |
| 2009-03-31 | $0.94B | $0.43B | 2.19 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $5.297B | $3.047B |
| Teleflex is a global provider of medical technology products. The company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company markets and sells its products to hospitals and healthcare providers worldwide through a combination of direct sales force and distributors. Teleflex has manufacturing operations located in the Czech Republic, Germany, Malaysia, Mexico and the United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $184.101B | 22.27 |
| Intuitive Surgical (ISRG) | United States | $172.528B | 71.51 |
| IDEXX Laboratories (IDXX) | United States | $51.032B | 53.11 |
| Edwards Lifesciences (EW) | United States | $45.970B | 30.47 |
| Alcon (ALC) | Switzerland | $43.470B | 29.38 |
| IQVIA Holdings (IQV) | United States | $32.732B | 18.50 |
| DexCom (DXCM) | United States | $31.694B | 47.54 |
| Mettler-Toledo (MTD) | United States | $27.012B | 32.06 |
| STERIS (STE) | Ireland | $24.087B | 25.64 |
| Waters (WAT) | United States | $17.226B | 23.66 |
| SONOVA HOLDING (SONVY) | Switzerland | $16.782B | 0.00 |
| Hologic (HOLX) | United States | $14.962B | 16.21 |
| Penumbra (PEN) | United States | $9.958B | 72.75 |
| Sysmex ADR (SSMXY) | Japan | $8.391B | 26.66 |
| Masimo (MASI) | United States | $8.362B | 28.14 |
| Globus Medical (GMED) | United States | $8.137B | 18.77 |
| Glaukos (GKOS) | United States | $5.134B | 0.00 |
| TransMedics (TMDX) | United States | $4.283B | 65.10 |
| Integer Holdings (ITGR) | United States | $3.698B | 18.45 |
| LivaNova (LIVN) | United Kingdom | $2.909B | 16.65 |
| Veracyte (VCYT) | United States | $2.366B | 32.69 |
| Alphatec Holdings (ATEC) | United States | $2.347B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $2.265B | 0.00 |
| Artivion (AORT) | United States | $2.022B | 102.02 |
| Nihon Kohden (NHNKY) | Japan | $1.999B | 23.86 |
| Elekta AB (EKTAY) | Sweden | $1.847B | 17.28 |
| OPKO Health (OPK) | United States | $1.111B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.095B | 6.27 |
| Pulse Biosciences (PLSE) | United States | $1.055B | 0.00 |
| IRadimed (IRMD) | United States | $0.892B | 43.28 |
| Beta Bionics (BBNX) | United States | $0.750B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $0.732B | 0.00 |
| AxoGen (AXGN) | United States | $0.713B | 0.00 |
| SiBone (SIBN) | United States | $0.670B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.573B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.522B | 9.22 |
| Semler Scientific (SMLR) | United States | $0.500B | 4.01 |
| OrthoPediatrics (KIDS) | United States | $0.481B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.445B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.399B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.376B | 9.57 |
| Delcath Systems (DCTH) | United States | $0.373B | 88.75 |
| AngioDynamics (ANGO) | United States | $0.357B | 0.00 |
| RxSight (RXST) | United States | $0.347B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.319B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.280B | 19.35 |
| NeuroPace (NPCE) | United States | $0.279B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.277B | 0.00 |
| Neuronetics (STIM) | United States | $0.234B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.232B | 0.00 |
| 908 Devices (MASS) | United States | $0.225B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.219B | 0.00 |
| Inogen (INGN) | United States | $0.204B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.190B | 0.00 |
| Accuray (ARAY) | United States | $0.182B | 0.00 |
| CVRx (CVRX) | United States | $0.180B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.172B | 0.00 |
| LENSAR (LNSR) | United States | $0.152B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.140B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.137B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.116B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.111B | 0.00 |
| InspireMD (NSPR) | United States | $0.104B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.102B | 0.00 |
| Hyperfine (HYPR) | United States | $0.100B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.096B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.076B | 0.00 | |
| QT Imaging Holdings (QTIH) | United States | $0.061B | 0.00 |
| Positron (POSC) | United States | $0.058B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.055B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.054B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.052B | 20.89 |
| WORK Medical Technology Group (WOK) | China | $0.045B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.040B | 0.00 |
| Precision Optics (POCI) | United States | $0.035B | 0.00 |
| Envoy Medical (COCH) | United States | $0.029B | 0.00 |
| DarioHealth (DRIO) | United States | $0.020B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.020B | 0.00 |
| NexGel (NXGL) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Tenon Medical (TNON) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.009B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (HIND) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.006B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.004B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 13.14 |